A detailed history of Baldwin Brothers LLC transactions in Haemonetics Corp stock. As of the latest transaction made, Baldwin Brothers LLC holds 215 shares of HAE stock, worth $18,896. This represents 0.0% of its overall portfolio holdings.

Number of Shares
215
Previous 215 -0.0%
Holding current value
$18,896
Previous $17,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 14, 2023

SELL
$80.84 - $89.45 $1,293 - $1,431
-16 Reduced 6.93%
215 $18,000
Q4 2022

Jan 27, 2023

SELL
$73.85 - $86.14 $5,169 - $6,029
-70 Reduced 23.26%
231 $0
Q2 2022

Jul 18, 2022

SELL
$49.27 - $66.08 $4,631 - $6,211
-94 Reduced 23.8%
301 $20,000
Q2 2021

Jul 30, 2021

SELL
$51.81 - $118.56 $3,108 - $7,113
-60 Reduced 13.19%
395 $26,000
Q1 2021

Apr 08, 2021

SELL
$111.01 - $139.48 $6,216 - $7,810
-56 Reduced 10.96%
455 $51,000
Q3 2020

Oct 16, 2020

SELL
$75.65 - $93.58 $16,945 - $20,961
-224 Reduced 30.48%
511 $45,000
Q2 2020

Jul 21, 2020

SELL
$84.96 - $118.91 $21,664 - $30,322
-255 Reduced 25.76%
735 $66,000
Q4 2019

Jan 29, 2020

SELL
$114.37 - $129.46 $3,087 - $3,495
-27 Reduced 2.65%
990 $114,000
Q3 2019

Oct 10, 2019

SELL
$117.16 - $138.52 $441,927 - $522,497
-3,772 Reduced 78.76%
1,017 $128,000
Q2 2019

Jul 19, 2019

SELL
$81.74 - $120.34 $90,731 - $133,577
-1,110 Reduced 18.82%
4,789 $576,000
Q1 2019

Apr 24, 2019

SELL
$83.25 - $102.12 $499,833 - $613,128
-6,004 Reduced 50.44%
5,899 $516,000
Q3 2018

Oct 26, 2018

SELL
$89.96 - $114.58 $74,936 - $95,445
-833 Reduced 6.54%
11,903 $1.36 Million
Q2 2018

Jul 24, 2018

SELL
$71.53 - $95.75 $205,577 - $275,185
-2,874 Reduced 18.41%
12,736 $1.14 Million
Q1 2018

Apr 16, 2018

SELL
$60.72 - $74.41 $139,352 - $170,770
-2,295 Reduced 12.82%
15,610 $1.14 Million
Q3 2017

Oct 26, 2017

BUY
$40.38 - $44.87 $723,003 - $803,397
17,905
17,905 $803,000

Others Institutions Holding HAE

About HAEMONETICS CORP


  • Ticker HAE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 51,316,500
  • Market Cap $4.51B
  • Description
  • Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...
More about HAE
Track This Portfolio

Track Baldwin Brothers LLC Portfolio

Follow Baldwin Brothers LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Baldwin Brothers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Baldwin Brothers LLC with notifications on news.